Keywords: merck, gets, fosamax, approval, co, bisphosphonate, drug

Merck gets Fosamax approval

Article | 03 July 1995

- Merck & Co's bisphosphonate drug Fosamax (alendronate) has been approved in Sweden for the treatment of postmenopausal osteoporosis. The drug is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Wyeth

Go to company listing

Related Drugs

Alendronate Sodium

Fosamax

Go to drug listing